To support Australian and New Zealand research in the fight against cancer, In Vitro Technologies offered 5 Travel Grants to Australian and New Zealand researchers to attend the Eradicate Cancer Conference in Melbourne in March 2018. And the winners are...
In Vitro Technologies Life Sciences division has a long history of supporting the Australian research community reaching back to 1958 and has developed a reputation for being one of the most dynamic and successful life science suppliers throughout Australia and New Zealand.
In Vitro Technologies are the premier supplier for cell biology and immunology research throughout Australia and New Zealand. Our range of cells, consumables, reagents, and laboratory equipment support your cell biology workflow in the fields of Cancer, Neuroscience, Immunology, Diabetes & Obesity, Cardiology, Pharmacology, and Drug Discovery. By partnering with world-class suppliers, In Vitro Technologies enables high quality, reproducible data, allowing researchers to accelerate discovery and publish high impact papers.
Great publication about improving the efficacy of adoptive T-Cell therapy in solid tumours by using 3rd generation CAR-T cells.
Scientists at the University of Oxford have described a new twist on cancer immunotherapy, combining two independent cell killing approaches in a single therapeutic with high potency and broad applicability.
In Vitro Technologies would like to congratulate Dr. Andreas Behren and the Cancer Immunobiology team at the Olivia Newton-John Cancer Research (ONJCRI) Institute in Melbourne for winning the Advanced Cell Diagnostics $40,000 USD research grant.